Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D1.293 - Urinary Levels of Environmental Pollutants Are Associated with the Severity and Persistence of Atopic Dermatitis in Young Children
D1.296 - Paediatric AD vs Food Allergy Management in the South of Ireland
D1.297 - The Effects of Virtual Reality on AD
D1.299 - The prevalence and management features of adolescents with atopic dermatitis under humanitarian crisis
D1.302 - The Fecal Microbiome: Geographical Location and Associated Dietary Habits Matter More Than Atopic Dermatitis
D1.291 - Hypertryptasemia and TPSAB1 allele β tryptase duplication, a case report
D1.292 - Assessing Quality of Life in Chronic Spontaneous Urticaria: Insights from DLQI Scores
D1.294 - Does food allergy test-guided dietary advice improve eczema control in children? Protocol for Trial of food allergy IgE tests for Eczema Relief (TIGER) study
D1.295 - Clinical, Laboratory and Prognostic Evaluation of Antinuclear Antibody Positive and Negative Children with Chronic Urticaria
D1.298 - Topical gluconolactone induces immune tolerance in cutaneous lupus erythematosus in human and mice
D1.300 - Alopecia areata associated with atopy has a distinct cytokine, chemokine and IgE profile
D1.303 - Preschooler with Toxic Epidermal Necrolysis Associated with Adenovirus Respiratory Infection
D1.304 - Occupational allergic contact dermatitis (Chronic hand eczema) to lily of the Incas and houseleek in a florist
D1.305 - Management of Contact Dermatitis in Pediatric Type 1 Diabetes: A Therapeutic Protocol with Topical Pimecrolimus
D1.306 - Is there a role of Genetics in Acute and Chronic Urticaria? A Systematic Review and Meta-analysis
D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data
D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases
D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin
D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity
D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download